Venn Life Sciences & Encorium to merge, add working capital
CROs Venn Life Sciences and Encorium are to merge and have secured working capital to expand the business.
Archives for February 20, 2012
MHRA suspends license of Teva generic over dissolution fears
The MHRA has suspended the license for a Teva generic over suggestions its dissolution rate could affect interchangeability.
Icon RFP value jumps 50% as bundling of services increases
The value of RFPs sent to Icon in 2011 jumped 50 per cent as companies that have yet to ink strategic deals began bundling services.
Another cancer drug recall at troubled CMO Ben Venue
Safety concerns prompt yet another recall at troubled US CMO Ben Venue with Bedford Labs pulling its leukaemia treatment cytarabine.
West proprietary delivery tech sales flat in the fourth quarter
West Pharmaceutical Services posted another flat quarter of proprietary delivery product sales but is predicting “notable increases” in 2012.
Catalent completes Aptuit deal
Catalent has acquired Aptuit’s trial supplies business, six months after the multimillion dollar agreement was announced.